Warner Pharmaceutical Factory announced that its holding subsidiary, Shanghai Zhigen Pharmaceutical Technology Co., Ltd., conducted a Phase I clinical trial of the ZG-1 capsule with the approval of the National Medical Products Administration has recently been completed. Zhigen Pharmaceutical and Peking An Ding Hospital, an affiliate of Capital Medical University, signed the project's "Cooperation Framework Agreement" for the joint development of the ZG-1 project in mainland China.